46 results
424B5
AXSM
Axsome Therapeutics Inc
28 Jun 23
Prospectus supplement for primary offering
8:16pm
and will be engaged in only with such persons.
MiFID II Product Governance
Any person offering, selling or recommending the shares (a “distributor
424B5
hz2xx02l
27 Jun 23
Prospectus supplement for primary offering
8:51pm
8-K/A
EX-99.1
mu1zki3c137rzmwhe
21 Jul 22
Abbreviated Financial Statements
4:46pm
8-K/A
EX-99.1
b61x924 qwih6e0g
31 Mar 22
Asset Purchase Agreement
4:45pm